Myocardial infarction results in wall motion abnormalities potentially associated with abnormal intracavitary blood flow patterns in the left ventricle. Magnetic resonance (MR) technique allows three-dimensional quantitative mapping of blood flow velocities. We performed three-dimensional MR velocity mapping in a modified left ventricular long axis plane in 10 patients with previous myocardial infarction and milder reduction of the left ventricular function. The early diastolic inflow pattern did not differ qualitatively from earlier published findings in normal subjects. At systole, a flow pattern similar to that found in normals was observed in 7 of our patients. In the remaining 3 patients two types of abnormal systolic flow patterns were observed resulting in a paradoxical flow directed towards the apex. The location and timing of the abnormal flow allowed a distinction between paradoxical flow into an aneurism and paradoxical flow towards an akinetic apex. Compared with other techniques currently available, three-dimensional MR velocity mapping permits a more detailed description and understanding of abnormal flow patterns caused by wall motion injury in patients with myocardial infarction. This potential of the method suggests that three-dimensional MR phase velocity mapping may become a useful tool in assessment of significance and treatment of regional left ventricular dysfunction.

Keywords:
Left ventricle, Myocardial infarction, Velocity mapping, Magnetic resonance, Blood flow
This content is only available via PDF.
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.